Stockscreener 앱 받기
8.99
5.64%
0.48
시간 외 거래:
8.99
전일 마감가:
$8.51
열려 있는:
$8.45
하루 거래량:
247.02K
Relative Volume:
0.71
시가총액:
$294.86M
수익:
$65.42M
순이익/손실:
$-32.96M
주가수익비율:
-7.0787
EPS:
-1.27
순현금흐름:
$-19.87M
1주 성능:
+0.11%
1개월 성능:
-14.22%
6개월 성능:
-34.67%
1년 성능:
+24.52%
1일 변동 폭
$8.25
$9.055
1주일 범위
$8.25
$9.09
52주 변동 폭
$5.45
$18.98
뉴로페이스 Stock (NPCE) Company Profile
명칭
Neuropace Inc
전화
(650) 237-2700
주소
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
NPCE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.99 | 279.12M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
뉴로페이스 Stock (NPCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-03-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | 개시 | Leerink Partners | Outperform |
| 2023-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-24 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 개시 | Lake Street | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 개시 | Robert W. Baird | Outperform |
| 2021-05-17 | 개시 | JP Morgan | Overweight |
| 2021-05-17 | 개시 | Morgan Stanley | Overweight |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 개시 | Wells Fargo | Overweight |
모두보기
뉴로페이스 주식(NPCE)의 최신 뉴스
NeuroPace Inc. Stock Analysis and ForecastGet daily updates on promising stocks - jammulinksnews.com
How volatile is NeuroPace Inc. stock compared to the marketGet expert advice on portfolio optimization - jammulinksnews.com
What institutional investors are buying NeuroPace Inc. stockGet exclusive access to professional stock picks - jammulinksnews.com
Is NeuroPace Inc. a growth stock or a value stockFree Stock Market Trend Analysis - jammulinksnews.com
What are analysts’ price targets for NeuroPace Inc. in the next 12 monthsHigh-octane gains - jammulinksnews.com
What catalysts could drive NeuroPace Inc. stock higher in 2025Rapid-fire capital growth - jammulinksnews.com
Is NeuroPace Inc. stock overvalued or undervaluedGet expert insights on market-moving stocks - jammulinksnews.com
What drives NeuroPace Inc. stock priceBuild wealth with high-performing stocks - jammulinksnews.com
How does NeuroPace Inc. generate profit in a changing economyGet daily expert analysis for smarter investing - jammulinksnews.com
Published on: 2025-08-03 08:27:39 - jammulinksnews.com
Is it the right time to buy NeuroPace Inc. stockExplosive trading opportunities - jammulinksnews.com
What makes NeuroPace Inc. stock price move sharplyTrack emerging stocks with high growth potential - jammulinksnews.com
What is the risk reward ratio of investing in NeuroPace Inc. stockGrow your wealth with proven stock picks - jammulinksnews.com
Essex Investment Management Co. LLC Acquires New Position in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases - The Manila Times
NeuroPace: CMS Maintains Current MS-DRG Assignment for RNS System Procedures - AInvest
NeuroPace Welcomes CMS Decision to Maintain FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases - AInvest
Medicare Maintains Critical Coverage: NeuroPace Epilepsy Treatment Reimbursement Secured for 2025 - Stock Titan
Published on: 2025-07-30 18:03:00 - metal.it
NeuroPace Inc. Earnings Report Breakdown: What Investors Should KnowPattern Alert With ROI Driven Strategy Shared - metal.it
Why NeuroPace Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - beatles.ru
Legato Capital Management LLC Purchases Shares of 41,107 NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 - 富途牛牛
How Efficient Is NeuroPace Inc. at Controlling Operating CostsReal Trader Watchlist of Hot Stocks Released - metal.it
What risks could impact NeuroPace Inc. stock performanceEarnings Play Trade Plan With Alerts Shared - metal.it
Should I hold or sell NeuroPace Inc. stock in 2025Market Forecast Alerts Backed By Experts - jammulinksnews.com
What markets is NeuroPace Inc. expanding into Is JKHY stock a good long term investment optionBeginner Investor Planner For Fast Growth - jammulinksnews.com
When is NeuroPace Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
Does NeuroPace Inc. stock perform well during market downturnsBuild wealth steadily with expert advice - jammulinksnews.com
How does NeuroPace Inc. compare to its industry peersHigh-performance stocks for savvy investors - jammulinksnews.com
What is the dividend policy of NeuroPace Inc. stockGame-changing capital returns - jammulinksnews.com
NeuroPace Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Investment Community - beatles.ru
What are NeuroPace Inc. company’s key revenue driversDiscover breakthrough trading strategies - jammulinksnews.com
What are the latest earnings results for NeuroPace Inc.Unlock powerful insights from market experts - jammulinksnews.com
What are the technical indicators suggesting about NeuroPace Inc.Find the best stocks for sustainable growth - jammulinksnews.com
How NeuroPace Inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser
뉴로페이스 (NPCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.17%
자본화:
|
볼륨(24시간):